ClinicalTrials.govpublic full text
Study of 5-fluorouracil (5-FU), Nab®1-paclitaxel, Bevacizumab, Leucovorin, and Oxaliplatin in Patients With Metastatic Pancreatic Cancer
metastatic pancreas adenocarcinoma, metastatic pancreatic cancer, adenocarcinoma, open-label, phase 1/2, metronomic, chemotherapy, abi-007, nab-paclitaxel, abraxane, gemcitabine, gemzar
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 851394
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.